- Home
- CSBR vs VWAV Comparison
CSBR vs VWAV Comparison
Compare CSBR & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- VWAV
- Stock Information
- Founded
- CSBR 1985
- VWAV 2024
- Country
- CSBR United States
- VWAV United States
- Employees
- CSBR N/A
- VWAV N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- VWAV Computer Software: Prepackaged Software
- Sector
- CSBR Health Care
- VWAV Technology
- Exchange
- CSBR Nasdaq
- VWAV Nasdaq
- Market Cap
- CSBR 123.2M
- VWAV 122.6M
- IPO Year
- CSBR 1986
- VWAV N/A
- Fundamental
- Price
- CSBR $6.60
- VWAV $9.02
- Analyst Decision
- CSBR Strong Buy
- VWAV
- Analyst Count
- CSBR 1
- VWAV 0
- Target Price
- CSBR $12.00
- VWAV N/A
- AVG Volume (30 Days)
- CSBR 26.8K
- VWAV 446.8K
- Earning Date
- CSBR 09-11-2025
- VWAV 08-19-2025
- Dividend Yield
- CSBR N/A
- VWAV N/A
- EPS Growth
- CSBR N/A
- VWAV N/A
- EPS
- CSBR 0.33
- VWAV N/A
- Revenue
- CSBR $56,944,000.00
- VWAV N/A
- Revenue This Year
- CSBR $9.30
- VWAV N/A
- Revenue Next Year
- CSBR $31.17
- VWAV N/A
- P/E Ratio
- CSBR $20.36
- VWAV N/A
- Revenue Growth
- CSBR 13.54
- VWAV N/A
- 52 Week Low
- CSBR $3.60
- VWAV $2.06
- 52 Week High
- CSBR $11.99
- VWAV $12.59
- Technical
- Relative Strength Index (RSI)
- CSBR 44.79
- VWAV N/A
- Support Level
- CSBR $6.51
- VWAV N/A
- Resistance Level
- CSBR $7.66
- VWAV N/A
- Average True Range (ATR)
- CSBR 0.45
- VWAV 0.00
- MACD
- CSBR 0.04
- VWAV 0.00
- Stochastic Oscillator
- CSBR 24.88
- VWAV 0.00
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About VWAV VisionWave Holdings Inc. Common Stock
VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.